Login to Your Account

Pro Bono Bio Lands $600M to Back its Nanotech Platform

By Nuala Moran

Tuesday, September 13, 2011
LONDON – A new Anglo-Russian biopharmaceutical company has been formed with $300 million from the Russian government, matched by a further $300 million from investors in the London-based private equity firm Celtic Pharma Holdings.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription